Nishal Zar, Khan Sangeen, Kamran Bilawal
Internal Medicine, University Hospitals of Morecambe Bay, Lancaster, GBR.
Internal Medicine, Fairfield General Hospital, Bury, GBR.
Cureus. 2025 Aug 5;17(8):e89418. doi: 10.7759/cureus.89418. eCollection 2025 Aug.
This systematic review explores the application of advanced neuroimaging techniques, diffusion tensor imaging (DTI) and functional MRI (fMRI), in identifying early neural alterations in patients with cognitive impairment and neurodegenerative disorders. By synthesizing data from nine recent clinical studies, the review highlights the integration of structural and functional imaging in detecting subtle brain connectivity changes associated with conditions such as mild cognitive impairment (MCI), Parkinson's disease, Alzheimer's disease, and subjective cognitive decline (SCD). The findings suggest that specific imaging parameters, including fractional anisotropy and task-based functional deactivation, correlate strongly with cognitive outcomes and therapeutic responses. Overall, this work underscores the potential of DTI and fMRI as valuable, non-invasive biomarkers for early detection and monitoring of cognitive decline, offering a foundation for improved diagnostic accuracy and timely interventions in clinical settings.
本系统评价探讨了先进的神经影像学技术,即扩散张量成像(DTI)和功能磁共振成像(fMRI),在识别认知障碍和神经退行性疾病患者早期神经改变方面的应用。通过综合九项近期临床研究的数据,该评价强调了结构和功能成像在检测与轻度认知障碍(MCI)、帕金森病、阿尔茨海默病和主观认知下降(SCD)等疾病相关的细微脑连接变化中的整合作用。研究结果表明,包括分数各向异性和基于任务的功能失活在内的特定成像参数与认知结果和治疗反应密切相关。总体而言,这项工作强调了DTI和fMRI作为早期检测和监测认知下降的有价值的非侵入性生物标志物的潜力,为提高临床诊断准确性和及时干预提供了基础。